Kirkland Lake Discoveries closes upsized $20.17 million brokered private placement led by Eric Sprott
Bitget2026/10/08 13:12Kirkland Lake Discoveries closed an upsized brokered private placement raising $20.17 million in gross proceeds. Issued 29,457,000 flow-through shares at $0.40, 5,714,000 special flow-through shares at $0.483, 16,066,510 common shares at $0.35. Eric Sprott led the strategic investment as the cornerstone order. Flow-through proceeds earmarked for Canadian exploration expenses by Dec. 31, 2027, with renunciation effective no later than Dec. 31, 2026. Hold period runs to Feb. 9, 2027; agents received 2,121,460 broker warrants exercisable at $0.35 for 24 months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kirkland Lake Discoveries Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610080912NEWSFILECNPR____20261008_318083_1) on October 08, 2026, and is solely responsible for the information contained therein.
- Kirkland Lake Discoveries closed an upsized brokered private placement raising $20.17 million in gross proceeds.
- Issued 29,457,000 flow-through shares at $0.40, 5,714,000 special flow-through shares at $0.483, 16,066,510 common shares at $0.35.
- Eric Sprott led the strategic investment as the cornerstone order.
- Flow-through proceeds earmarked for Canadian exploration expenses by Dec. 31, 2027, with renunciation effective no later than Dec. 31, 2026.
- Hold period runs to Feb. 9, 2027; agents received 2,121,460 broker warrants exercisable at $0.35 for 24 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
